Published in Women's Health Weekly, June 7th, 2001
These therapies would override mutations on growth factor genes normally responsible for the development of tissues within the circulatory system during embryonic growth, authors of the new research indicate.
"Major congenital malformations, including those affecting the cardiovascular system, remain the leading cause of mortality and morbidity in infants of diabetic mothers," said Emese Pinter of Yale University School of Medicine, who worked with researchers in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly